Page last updated: 2024-11-03

praziquantel and Dysgerminoma

praziquantel has been researched along with Dysgerminoma in 1 studies

azinox: Russian drug

Dysgerminoma: A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Górgolas, M1
Casado, V1
Renedo, G1
Alen, JF1
Fernández Guerrero, ML1

Other Studies

1 other study available for praziquantel and Dysgerminoma

ArticleYear
Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma.
    The American journal of tropical medicine and hygiene, 2009, Volume: 81, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dysgerminoma; Eosinophilia; Female; Humans; L

2009